Sort by
Refine Your Search
-
ETH Zurich, Institute for Mathematical Research Position ID: 2549-HWI [#27223] Position Title: Position Type: Postdoctoral Position Location: Zurich, Zurich 8092, Switzerland [map ] Subject Area: All areas of mathematics Starting Date: 2026/09/01 Appl Deadline: 2025/11/02 03:59 AM...
-
postdoc to join its research team studying the political economy of low-carbon technologies (LCTs) and climate policy. The PET group adopts an interdisciplinary, mixed-method approach grounded in political
-
, chemists, materials scientists, and electrical engineers focusing on physics and chemistry of soft electronic materials for new optoelectronic devices and integrated systems. We aim to hire 1 – 2 postdoc
-
for a reliable, enthusiastic, and highly motivated postdoc with a passion for science to join our team in Zurich. Our research focuses on process- and system-understanding of the biosphere-atmosphere
-
following documents: Motivation letter (max. 2 pages) Curriculum Vitae (CV) Academic transcripts and diplomas (Bachelor and Master) Master thesis and/or proof of thesis grade (e.g., grading confirmation
-
Preparation of scientific manuscripts and contribution to research proposals The postdoc will work closely with Prof. Anthony Straub to carry out these responsibilities. Opportunities exist to interface with
-
, or interpretability are relevant LLM adaptive evaluation and post-training, with clean mathematical proofs for proof-of-concept
-
a postdoc in this project, you will: Establish and characterize human neuron-tumor co-cultures using iPSC-derived neurons and patient-derived GB models on HD-MEAs Perform longitudinal
-
environment. The Postdoctoral Fellowship Program, made possible via our Strategic Partnership with Halter Group AG , funds a two-year postdoc position annually over 5 years. The goal is to advance computational
-
100%, Basel, fixed-term The highly competitive Bio-Engineering Systems for Therapeutics (BEST) postdoc program, part of the Next-gen Bioengineers initiative, is run jointly by ETH Zurich and Roche